Surgical Innovations logo

SUN - Surgical Innovations News Story

2.5p 0.0  0.0%

Last Trade - 15/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £19.8m
Enterprise Value £20.8m
Revenue £10.8m
Position in Universe 1368th / 1810

Surgical Innovations - Exercise of Options, Issue of Equity and TVR

Fri 27th September, 2019 3:40pm
RNS Number : 0145O
Surgical Innovations Group PLC
27 September 2019
 

 

27 September 2019

Surgical Innovations Group plc 

("SI Group" or "the Company")

 

Exercise of Options, Issue of Equity & Total Voting Rights

 

 

Exercise of Options

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 4,750,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") following an exercise of options.

 

Application has been made to the London Stock Exchange for the 4,750,000 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on 3 October 2019.

 

Total Voting Rights

Following Admission, the Company will have 795,316,177 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 795,316,177.

 

 

 

For further information please contact:

 

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Non-Executive Chairman

Tel: 0113 230 7597

Charmaine Day, Company Secretary & GFC




N+1 Singer  (Nominated Advisor and Broker)

Richard Lindley

Tel: 020 7496 3000

 

Rachel Hayes

 


Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Lianne Cawthorne

Mob: 07980 541 893

Mob: 07584 391 303

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRLLFVSARIDFIA
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.